Observing symptoms after thyroid surgery in cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the safety and efficacy of postoperative management in patients with thyroid cancer who have undergone subtotal or total thyroidectomy. It involves a comprehensive analysis of the quality of life and symptoms experienced by these patients post-surgery. The study aims to assess the effectiveness and safety of treatments for postoperative symptoms and analyze prognostic factors related to disease-free and overall survival. Additionally, it seeks to establish a database for future research on cancer management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 19 years of age or older
* Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging
* Subjects who have undergone partial thyroidectomy or total resection within 1 month
* Those who have agreed to the implementation of Chinese medicine treatment
* The Eastern Cooperative Oncology Group(ECOG) performance status 0-3
* Those who understand the content of the study and agree to participate in the study

Exclusion Criteria:

* ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function

  * When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out
  * When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment
  * Pregnant and lactating women
  * Other researchers who are judged to be unsuitable for research

Where it's running

• Bundang Cha Hospital
  Gyeonggi-do, South Korea Recruiting
• Ilsan Cha Hospital
  Gyeonggi-do, South Korea Recruiting
• Gangnam Cha Hospital
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Jee Youg Lee — Ilsan Cha hospital
• Study coordinator: Jee Youg Lee
• Email: happiade@chamc.co.kr
• Phone: 082-31-782-3113

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer

  In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.

  Recruiting Phase 2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07874321

• Selective coverage radiotherapy vs. full coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer

  This trial tests whether covering only the tumor-affected area with radiation is as effective as full-area coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer, while aiming to reduce side effects and improve quality of life.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT07777536

• Trop-2 Targeted PET/CT for Recurrent and Metastatic Thyroid Cancer

  This study tests whether a Trop-2 targeted PET/CT scan can better detect recurrent or metastatic thyroid cancer in adults than another PET/CT scan (FAPI).

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07753499

• WeChat-supported neck exercises after thyroidectomy

  A telehealth program using a WeChat mini program tests if guided neck exercises after thyroid surgery help early recovery and quality of life.

  Recruiting Shanghai 6th People's Hospital · Shanghai, Shanghai Municipality · NCT07707401

• Pralsetinib Drug Interaction Study in RET Fusion/MUTATION Positive Solid Tumors

  This trial tests whether pralsetinib changes how the body processes certain medicines in adults with RET fusion- or mutation-positive advanced solid tumors.

  Recruiting at 2 sites Phase 4 Rigel Pharmaceuticals · Logroño, La Rioja and 1 other locations · NCT07704658

• AI chatbot to guide thyroid cancer patients through perioperative education

  A new AI chatbot is being tested to see if it helps thyroid cancer patients better prepare for discharge, recover well, and stay engaged in their care compared with traditional education.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07634978

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.